Researchers have found that a decrease in scar-generating cell death called ferroptosis may be a mechanism that drives IPF.

A funny thing happened the other day on the way to the Pulmonary Fibrosis News Forums. In the blink of an eye, everything changed, and off I went to the emergency room at Inova Fairfax Hospital in ...

GRI Bio‘s experimental oral therapy GRI-0621 (tazarotene) has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF) ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google I recently received my first Rituxan (rituximab) infusion. Most ...

The need for naps tends to evolve throughout one’s lifetime. When my kids were babies, it was good to let their young bodies rest midday, giving their parents a break and helping them gradually adjust ...

Vaccines based on protein fragments unique to the scar-forming cells that drive idiopathic pulmonary fibrosis (IPF) significantly reduced lung scarring in both mouse models and human cell experiments, ...

A regulatory committee of the European Medicines Agency is urging approval of the oral therapy Jascayd (nerandomilast) in the European Union for treating adults with idiopathic pulmonary fibrosis (IPF ...

While oxygen therapy does not directly address the underlying cause of pulmonary fibrosis or halt the progression of the disease, it is an important therapy that improves symptoms and organ function.

Two Phase 3 clinical trials testing Tyvaso (treprostinil) in people with idiopathic pulmonary fibrosis (IPF) both met their main goals, showing that the inhalation therapy significantly outperformed a ...

Insilico Medicine will soon launch an early clinical trial in China to test an inhaled version of its therapy candidate rentosertib in healthy volunteers and people with idiopathic pulmonary fibrosis ...

What is LTI-03 for pulmonary fibrosis? LTI-03 is an experimental inhaled therapy that’s being tested as a possible treatment to preserve lung function and slow disease progression in idiopathic ...